鈣衛(wèi)蛋白(CALPRO)重組蛋白
Recombinant Calprotectin (CALPRO)
MRP-8/MRP-14; S100A8/A9
- 編號URPK504Hu01
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細(xì)胞定位分泌
- 預(yù)測分子量12/14kDa
- 實(shí)際分子量14/16kDa(差異分析請參閱說明書)
- 片段與標(biāo)簽Met1~Glu93 and Met1~Pro114 co-expression with N-terminal His Tag
- 緩沖液成份20mM Tris, 150mM NaCl, pH8.0, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 95%
- 等電點(diǎn)6.0
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 583 ¥ 1458 ¥ 2916 ¥ 8748 ¥ 21870
- 欲了解實(shí)際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Figure . Gene Sequencing (extract)
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| UEPK504Hu61 | 鈣衛(wèi)蛋白(CALPRO)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPK504Hu01 | 鈣衛(wèi)蛋白(CALPRO)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UAPK504Hu61 | 鈣衛(wèi)蛋白(CALPRO)活性蛋白 | Cell?culture;?Activity?Assays. |
| UPAK504Hu01 | 鈣衛(wèi)蛋白(CALPRO)多克隆抗體 | WB; IHC |
| UMAK504Hu21 | 鈣衛(wèi)蛋白(CALPRO)單克隆抗體 | WB |
| UMAK504Hu23 | 鈣衛(wèi)蛋白(CALPRO)單克隆抗體 | WB |
| UMAK504Hu24 | 鈣衛(wèi)蛋白(CALPRO)單克隆抗體 | WB |
| UMAK504Hu22 | 鈣衛(wèi)蛋白(CALPRO)單克隆抗體 | WB |
| UFAK504Hu02 | 抗鈣衛(wèi)蛋白(CALPRO)單克隆抗體 | FCM |
| UFAK504Hu04 | 抗鈣衛(wèi)蛋白(CALPRO)單克隆抗體 | FCM |
| UFAK504Hu06 | 抗鈣衛(wèi)蛋白(CALPRO)單克隆抗體 | FCM |
| UFAK504Hu08 | 抗鈣衛(wèi)蛋白(CALPRO)單克隆抗體 | FCM |
| ULAK504Hu72 | 鈣衛(wèi)蛋白(CALPRO)單克隆抗體(生物素標(biāo)記) | WB |
| USEK504Hu | 鈣衛(wèi)蛋白(CALPRO)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMK504Hu | 鈣衛(wèi)蛋白(CALPRO)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| UPSK504Hu01 | 鈣衛(wèi)蛋白(CALPRO)抗體對 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
| UKSK504Hu01 | 鈣衛(wèi)蛋白(CALPRO)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Medicine (Baltimore) | A Novel Combination of Calprotectin and CXCL12 for Predicting Malignancy in Patients with Exudative Pleural Effusion [PubMed: 26632726] |
| Neurochemical?Research? | Effects?of (-)-Sesamin?on?Chronic?Stress-Induced?Anxiety?Disorders?in?Mice [pubmed:27995494] |
| International journal of molecular sciences | Immune Modulating Topical S100A8/A9 Inhibits Growth of Pseudomonas aeruginosa and Mitigates Biofilm Infection in Chronic Wounds. [pubmed:28672877] |
| Analytical Chemistry? | Multiplex Immuno-MALDI-TOF MS for Targeted Quantification of Protein Biomarkers and Their Proteoforms Related to Inflammation and Renal Dysfunction [Pubmed:29420882] |
| ?JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH | Maternal serum calprotectin level in intrahepatic cholestasis of pregnancy [34254410] |
| Bull Exp Biol Med | Influence of Rectal Ozone Application on the Intensity of Free Radical Destruction of Lipids and Intestinal Proteins in the Dynamics of Experimental Colitis [Pubmed:35622259] |
| Serum Calprotectin and Iron Metabolism Biomarker Levels in Beh?et's Disease [] |
留言咨詢
